2026 Summer Intern – Medical Affairs, Reproductive Medicine at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries

Requirements

  • Currently enrolled in Bachelor’s degree program (rising junior or rising senior preferred)
  • Interest in life sciences sector and major in biology/life sciences
  • Ability to synthesize data and interested to acquire new knowledge
  • Strong proficiency in English communication (verbal and written)
  • Competency in Microsoft PPT and Excel highly preferred
  • Ability to work in ambiguity, take initiative, and ask questions
  • Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
  • Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline)
  • Currently enrolled in an accredited U.S. based college or university
  • Enrolled in either an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
  • Legally authorized to work in the U.S. without a need for sponsorship/CPT/OPT now or in the future
  • At least 18 years of age prior to the scheduled start date
  • Must be available to complete virtual interviews with HR and hiring manager
  • Must successfully pass a drug screen and background check prior to start date
  • Must complete a final presentation at the end of the 10-week program (mandatory)
  • For Parsippany-based roles: Expected to work no less than 4 days at the site in Parsippany, New Jersey, with up to 1 day per week remotely

Responsibilities

  • Support the preparation for Reproductive Medicine product launch by assisting in the development of key launch materials and resources
  • Collaborate with cross-functional Medical Affairs teams—including Field Medical, MOVL, Publications, HEOR, RWE, and Medical Information—to coordinate and track launch-related activities
  • Help monitor progress against launch milestones, ensure alignment across workstreams, and contribute to internal updates and presentations

Skills

Key technologies and capabilities for this role

Medical AffairsReproductive MedicineLaunch PlanningBrand PlanningCross-Functional CollaborationData GenerationMedical EducationScientific CommunicationHEORRWEPublications

Questions & Answers

Common questions about this position

What is the work location and remote policy for this internship?

This role is based in Parsippany, New Jersey, and requires working no less than 4 days per week at the site, with the option to work 1 day per week remotely.

What are the educational and skill requirements for this internship?

Candidates must be currently enrolled in a Bachelor’s degree program (rising junior or senior preferred) with a major in biology or life sciences, a cumulative 3.0 GPA or above, strong proficiency in English communication, and competency in Microsoft PPT and Excel.

What are the dates and time commitment for the internship?

The internship runs for 10 weeks from May 26, 2026 to July 31, 2026, requiring a commitment of 37.5 hours per week.

What is the compensation for this internship?

This information is not specified in the job description.

What qualities make a strong candidate for this role?

Strong candidates have a 3.0 GPA or above, the ability to synthesize data, work in ambiguity, take initiative, ask questions, and provide college transcripts.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI